000 01252 a2200349 4500
005 20250518015559.0
264 0 _c20190708
008 201907s 0 0 eng d
022 _a1532-5520
024 7 _a10.1097/GRF.0000000000000417
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShyken, Jaye M
245 0 0 _aBenzodiazepines in Pregnancy.
_h[electronic resource]
260 _bClinical obstetrics and gynecology
_c03 2019
300 _a156-167 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Anxiety Agents
_xadministration & dosage
650 0 4 _aAnxiety
_xcomplications
650 0 4 _aBenzodiazepines
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aPregnancy
650 0 4 _aPremature Birth
_xetiology
650 0 4 _aPrenatal Exposure Delayed Effects
_xetiology
650 0 4 _aSubstance Withdrawal Syndrome
_xphysiopathology
650 0 4 _aSubstance-Related Disorders
_xepidemiology
700 1 _aBabbar, Shilpa
700 1 _aBabbar, Shaweta
700 1 _aForinash, Alicia
773 0 _tClinical obstetrics and gynecology
_gvol. 62
_gno. 1
_gp. 156-167
856 4 0 _uhttps://doi.org/10.1097/GRF.0000000000000417
_zAvailable from publisher's website
999 _c29240263
_d29240263